Andrew von Eschenbach, M.D., Former FDA Commissioner and Leading Prostate Cancer Expert, Elected to Viamet Pharmaceuticals Board of Directors

Viamet Pharmaceuticals has named Dr. Andy von Eschenbach, former FDA Commissioner and former Director of the National Cancer Institute, to its Board of Directors. Dr. von Eschenbach's expertise in urology, prostate cancer research, patient healthcare poli... [more]

View complete Press Release article